Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0106 | 1 | 0.5 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0106 | 1 | 1 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.0058 | 0.0885 | 0.0885 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0066 | 0.2407 | 0.167 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0058 | 0.0885 | 0.5 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0106 | 1 | 1 |
Trypanosoma cruzi | p450 reductase, putative | 0.0106 | 1 | 0.5 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0054 | 0.0151 | 0.0151 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0058 | 0.0885 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0094 | 0.7743 | 0.5 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0106 | 1 | 0.5 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0058 | 0.0885 | 0.0885 |
Leishmania major | p450 reductase, putative | 0.0106 | 1 | 1 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.0058 | 0.0885 | 0.0885 |
Schistosoma mansoni | coup transcription factor | 0.0058 | 0.0885 | 0.0885 |
Schistosoma mansoni | thyroid hormone receptor | 0.0058 | 0.0885 | 0.0885 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0106 | 1 | 0.5 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.0058 | 0.0885 | 0.0885 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.0058 | 0.0885 | 0.0885 |
Loa Loa (eye worm) | hypothetical protein | 0.0106 | 1 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0053 | 0 | 0.5 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.0058 | 0.0885 | 0.0885 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0106 | 1 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0053 | 0 | 0.5 |
Onchocerca volvulus | 0.0058 | 0.0885 | 0.5 | |
Echinococcus multilocularis | methionine synthase reductase | 0.0066 | 0.2407 | 0.167 |
Chlamydia trachomatis | sulfite reductase | 0.0066 | 0.2407 | 0.5 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0106 | 1 | 1 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0094 | 0.7743 | 0.5 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0106 | 1 | 0.5 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0106 | 1 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0106 | 1 | 1 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0106 | 1 | 1 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0058 | 0.0885 | 0.5 |
Schistosoma mansoni | nuclear hormone receptor | 0.0058 | 0.0885 | 0.0885 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.0058 | 0.0885 | 0.0885 |
Brugia malayi | FAD binding domain containing protein | 0.0066 | 0.2407 | 0.167 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0106 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0106 | 1 | 0.5 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0066 | 0.2407 | 0.2407 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.0058 | 0.0885 | 0.0885 |
Schistosoma mansoni | thyroid hormone receptor | 0.0058 | 0.0885 | 0.0885 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0106 | 1 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0106 | 1 | 0.5 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0106 | 1 | 0.5 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.0058 | 0.0885 | 0.0885 |
Echinococcus granulosus | methionine synthase reductase | 0.0066 | 0.2407 | 0.167 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0106 | 1 | 0.5 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0106 | 1 | 1 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0106 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Residual binding (binding) | = 100 % | Residual binding of radiolabelled PGE-2 on the Prostanoid EP3 receptor at a concentration of 1 microM | ChEMBL. | 11266183 |
Residual binding (binding) | = 100 % | Residual binding of radiolabelled PGE-2 on the Prostanoid EP3 receptor at a concentration of 1 microM | ChEMBL. | 11266183 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.